Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block vs ESP Block for Analgesia in Abdominal Surgery
NCT05446727Completed
- Sponsor
- Jagiellonian University
- Start
- May 2022
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Jagiellonian University. Primary endpoint: Total long acting opioid consumption in oxycodone equivalents at 1 day. Started May 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05446727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05446727.